| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |